Gilead Sciences donates 5,000 remdesivir vials for emergency use amid the Marburg virus outbreak in Rwanda, as the country plans clinical trials for new treatments.
Gilead Sciences donates 5,000 remdesivir vials for emergency use amid the Marburg virus outbreak in Rwanda, as the country plans clinical trials for new treatments.
The African Spectator stands as the compass for those seeking lucid, objective, and insightful commentary on Africa’s ever-evolving political and social landscape.
© 2024 The African Spectator. All Rights Reserved.